Skip to content

ECHOMEDIC

Active
Private limited companyfounded 2007active for 18 yearsKarrewegstraat 102, 9800 Deinze, BelgiumKBO/BCE: BE 0893.763.047
Summary

ECHOMEDIC has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €587,656 and a net result of €99,673. Equity is growing by about 26% per year across the filed financial years. Its solvency ranks better than 57% of 12,737 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
ECHOMEDICActiveChecked score 88/100
Risk analysis ReportCompare

History

ECHOMEDIC was incorporated on 27 November 2007.1 The registered office was moved to Deinze in 2025.2 Total assets rose from €382,059 in 2018 to €1.4m in 2025 and headcount from 0.2 full-time equivalents in 2019 to 1 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 18-12-2025
  3. 3National Bank, annual accounts 2018, 2019 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
23-07
NBB filing Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial Equity above €500,000equity €587,656 ▲20.4%
A profit in every financial year since 2018 builds equity to €587,656.
18-12
Gazette deed Resignation: MD Medic (director)
Permanent representatives: Manon Hebberecht, Yves-Charles Restif and 3 others · Appointments: YC Invest, AS3M and YST Group · Power of attorney14 facts ▸
  • Director resignation, MD Medic (director)
  • Permanent representative, Manon Hebberecht
  • Director appointment, YC Invest (director)
  • Permanent representative, Yves-Charles Restif
  • Director appointment, AS3M (director)
  • Permanent representative, Artur Manuel De Jesus Alves
  • Director appointment, YST Group (director)
  • Permanent representative, Sebastiaan Tavernier
  • Power of attorney, ABC Advisory BV
  • Permanent representative, Soraya El Khounchar
  • Board meeting, 16-05-2025
  • Director appointment, YST Group (managing director)
  • +2 further facts in this act
19-08
NBB filing Annual accounts filed
financial year 2024 · micro format · 19 days late
14-04
Gazette deed Appointment: MD MEDIC (director)
Permanent representative: HEBBERECHT Manon Anna Elena · Capital conversion · Amendment of the articles14 facts ▸
  • General meeting, 09-04-2025
  • Other provision, “aanpassing statuten aan WVV en behoud rechtsvorm, EERSTE BESLUIT” (deed in Dutch)
  • Other provision, “Lamoraal van Emontstraat 20,9000 Gent” (deed in Dutch)
  • Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Capital conversion, “beschikbaar eigen vermogen” (deed in Dutch)
  • Other provision, “geen uitkering eigen vermogen, artikel 5:142 en 5:143 WVV” (deed in Dutch)
  • Other provision, 01-01-2020, “nieuwe terminologie WVV” (deed in Dutch)
  • Director appointment, MD MEDIC (director (not named in the articles))
  • Permanent representative, HEBBERECHT Manon Anna Elena
  • Amendment of the articles
  • Other provision, “Hoofdstuk VII Algemene bepalingen” (deed in Dutch)
  • Registered office clause, “Gent, Lamoraal van Egmontstraat 20” (deed in Dutch)
  • +2 further facts in this act
2024
31-12
Financial Weakest financial yearnet €702 ▼98.7%
Net result drops to €702, the lowest in the series; recovery starts the following year.
30-09
Gazette deed Resignation: OGFBV (director)
Appointment: MDMedicBV (director) · Registered-office move4 facts ▸
  • General meeting, 10-07-2024
  • Director resignation, OGFBV (director)
  • Director appointment, MDMedicBV (director)
  • Registered-office move, LamoraalvanEgmontstraat20,9000Gent
31-07
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
30-08
NBB filing Annual accounts filed
financial year 2022 · micro format · 30 days late
2022
31-12
Financial Highest result from 2018 to 2025net €190,234 ▲142%
Operating result €250,369, net result €190,234, both a record.
30-09
NBB filing Annual accounts filed
financial year 2021 · micro format · 61 days late
2021
31-12
Financial Equity above €200,000equity €244,185 ▲47.4%
A profit in every financial year since 2018 builds equity to €244,185.
Show earlier events
31-08
NBB filing Annual accounts filed
financial year 2020 · micro format · 31 days late
2020
30-09
NBB filing Annual accounts filed
financial year 2019 · micro format · 61 days late
2019
31-12
Financial Equity above €150,000equity €152,853 ▲4.3%
A profit in every financial year since 2018 builds equity to €152,853.
27-08
NBB filing Annual accounts filed
financial year 2018 · micro format · 27 days late
2018
31-08
NBB filing Annual accounts filed
financial year 2017 · micro format · 31 days late
2017
02-08
NBB filing Annual accounts filed
financial year 2016 · abbreviated format · 2 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 18 annual accounts filed, the latest 10 are here; all 18 are under Financials.
3 of 5 deeds read
About the unread acts

Of the 5 Belgian Official Gazette deeds we know for this company, 3 have been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

We would like to set cookies. That happens only with your consent. What we measure